NASDAQ:RCKT - Rocket Pharmaceuticals News Headlines

$17.13
+0.21 (+1.24 %)
(As of 06/19/2019 04:00 PM ET)
Today's Range
$16.63
Now: $17.13
$17.37
50-Day Range
$14.94
MA: $17.18
$19.81
52-Week Range
$10.75
Now: $17.13
$25.96
Volume16,340 shs
Average Volume203,583 shs
Market Capitalization$861.47 million
P/E RatioN/A
Dividend YieldN/A
Beta3

Headlines

Rocket Pharmaceuticals (NASDAQ RCKT) News Headlines

Source:
DateHeadline
Rocket Pharma begins patient dosing in early-stage RP-A501 trialRocket Pharma begins patient dosing in early-stage RP-A501 trial
seekingalpha.com - June 18 at 5:29 PM
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) Given Average Recommendation of "Buy" by AnalystsRocket Pharmaceuticals Inc (NASDAQ:RCKT) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 14 at 8:51 AM
-$0.49 Earnings Per Share Expected for Rocket Pharmaceuticals Inc (NASDAQ:RCKT) This Quarter-$0.49 Earnings Per Share Expected for Rocket Pharmaceuticals Inc (NASDAQ:RCKT) This Quarter
www.americanbankingnews.com - June 9 at 12:21 AM
Rocket Pharmaceuticals Sponsors 3rd Annual PKD Patients’ ForumRocket Pharmaceuticals Sponsors 3rd Annual PKD Patients’ Forum
finance.yahoo.com - June 6 at 6:01 PM
Did You Manage To Avoid Rocket Pharmaceuticalss (NASDAQ:RCKT) 19% Share Price Drop?Did You Manage To Avoid Rocket Pharmaceuticals's (NASDAQ:RCKT) 19% Share Price Drop?
finance.yahoo.com - May 23 at 6:37 PM
Did You Manage To Avoid Rocket Pharmaceuticals's (NASDAQ:RCKT) 19% Share Price Drop?Did You Manage To Avoid Rocket Pharmaceuticals's (NASDAQ:RCKT) 19% Share Price Drop?
finance.yahoo.com - May 23 at 6:37 PM
Here’s What Hedge Funds Think About Rocket Pharmaceuticals, Inc. (RCKT)Here’s What Hedge Funds Think About Rocket Pharmaceuticals, Inc. (RCKT)
finance.yahoo.com - May 9 at 6:44 PM
Rocket Pharmaceuticals Announces Participation at the Bank of America Merrill Lynch 2019 Healthcare ConferenceRocket Pharmaceuticals Announces Participation at the Bank of America Merrill Lynch 2019 Healthcare Conference
finance.yahoo.com - May 7 at 9:19 AM
Rocket Pharmaceuticals Presents Preclinical Data of RP-A501 for Danon Disease at the American Society of Gene and Cell Therapy 2019 Annual MeetingRocket Pharmaceuticals Presents Preclinical Data of RP-A501 for Danon Disease at the American Society of Gene and Cell Therapy 2019 Annual Meeting
finance.yahoo.com - May 2 at 9:26 AM
Rocket Pharma nabs $6.5M grant to support gene therapy developmentRocket Pharma nabs $6.5M grant to support gene therapy development
seekingalpha.com - April 30 at 6:06 PM
Rocket Pharmaceuticals Receives Funding from the California Institute for Regenerative Medicine (CIRM)Rocket Pharmaceuticals Receives Funding from the California Institute for Regenerative Medicine (CIRM)
finance.yahoo.com - April 30 at 9:15 AM
Rocket prices stock offering at $17.50Rocket prices stock offering at $17.50
seekingalpha.com - April 16 at 9:52 AM
Rocket Pharma prices stock offering at $17.50Rocket Pharma prices stock offering at $17.50
seekingalpha.com - April 16 at 9:52 AM
10 Stocks To Watch For April 16, 201910 Stocks To Watch For April 16, 2019
feeds.benzinga.com - April 16 at 5:52 AM
Rocket Pharmaceuticals Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 2019 Annual MeetingRocket Pharmaceuticals Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting
finance.yahoo.com - April 15 at 6:28 PM
Noteworthy Thursday Option Activity: RCKT, TWLO, AWRNoteworthy Thursday Option Activity: RCKT, TWLO, AWR
www.nasdaq.com - March 21 at 6:34 PM
First Week of May 17th Options Trading For Rocket PharmaceuticalsFirst Week of May 17th Options Trading For Rocket Pharmaceuticals
www.nasdaq.com - March 21 at 6:34 PM
Rocket Pharmaceuticals IncRocket Pharmaceuticals Inc
www.bloomberg.com - March 19 at 9:40 AM
Rocket Pharma up 8% ahead of presentations at ACCRocket Pharma up 8% ahead of presentations at ACC
seekingalpha.com - March 15 at 6:30 PM
Rocket Pharmaceuticals Announces Presentations at the American College of Cardiology 2019 Annual MeetingRocket Pharmaceuticals Announces Presentations at the American College of Cardiology 2019 Annual Meeting
finance.yahoo.com - March 15 at 9:42 AM
Rocket Pharmaceuticals Sponsors Clinical Trial at University of California, Los Angeles (UCLA) - Business WireRocket Pharmaceuticals Sponsors Clinical Trial at University of California, Los Angeles (UCLA) - Business Wire
www.businesswire.com - March 13 at 6:14 PM
Rocket Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of RP-L102 in the U.S. - Business WireRocket Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of RP-L102 in the U.S. - Business Wire
www.businesswire.com - March 13 at 6:14 PM
Dosing underway in Rocket Pharma early-stage study of RP-L102 in rare anemiaDosing underway in Rocket Pharma early-stage study of RP-L102 in rare anemia
seekingalpha.com - March 12 at 10:21 AM
Rocket Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of RP-L102 in the U.S.Rocket Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of RP-L102 in the U.S.
finance.yahoo.com - March 12 at 10:21 AM
Are Insiders Selling Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Stock?Are Insiders Selling Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Stock?
finance.yahoo.com - March 12 at 10:21 AM
Rocket Pharma sponsors clinical trial for LAD-I and IMORocket Pharma sponsors clinical trial for LAD-I and IMO
seekingalpha.com - March 11 at 11:10 AM
Rocket Pharmaceuticals Sponsors Clinical Trial at University of California, Los Angeles (UCLA)Rocket Pharmaceuticals Sponsors Clinical Trial at University of California, Los Angeles (UCLA)
finance.yahoo.com - March 11 at 11:10 AM
Rocket Pharmaceuticals Reports Full Year 2018 Financial Results and Operational HighlightsRocket Pharmaceuticals Reports Full Year 2018 Financial Results and Operational Highlights
finance.yahoo.com - March 7 at 9:51 AM
Rocket Pharmaceuticals Announces Participation at Upcoming Conferences - Business WireRocket Pharmaceuticals Announces Participation at Upcoming Conferences - Business Wire
www.businesswire.com - March 5 at 5:59 PM
Rocket Pharmaceuticals Recognizes Rare Disease Day® 2019Rocket Pharmaceuticals Recognizes Rare Disease Day® 2019
finance.yahoo.com - February 28 at 9:27 AM
Rocket Pharmaceuticals Announces Publication of Comprehensive Review of Danon Disease Cases in the International Journal of Cardiology - Business WireRocket Pharmaceuticals Announces Publication of Comprehensive Review of Danon Disease Cases in the International Journal of Cardiology - Business Wire
www.businesswire.com - February 26 at 9:47 AM
Rocket Pharmaceuticals Announces Publication of Comprehensive Review of Danon Disease Cases in the International Journal of CardiologyRocket Pharmaceuticals Announces Publication of Comprehensive Review of Danon Disease Cases in the International Journal of Cardiology
finance.yahoo.com - February 26 at 9:47 AM
Rocket Pharmaceuticals Announces Participation in Fireside Chat at the 8th Annual SVB Leerink Global Healthcare ConferenceRocket Pharmaceuticals Announces Participation in Fireside Chat at the 8th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 20 at 9:36 AM
FDA clears Rocket Pharmas IND for RP-A501FDA clears Rocket Pharma's IND for RP-A501
seekingalpha.com - January 22 at 9:24 AM
Rocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy for Danon DiseaseRocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy for Danon Disease
finance.yahoo.com - January 22 at 9:24 AM
Form 8-K ROCKET PHARMACEUTICALS, For: Dec 27 - StreetInsider.comForm 8-K ROCKET PHARMACEUTICALS, For: Dec 27 - StreetInsider.com
www.streetinsider.com - December 29 at 9:18 AM
Rocket Pharmaceuticals to join NBI - Seeking AlphaRocket Pharmaceuticals to join NBI - Seeking Alpha
seekingalpha.com - December 22 at 4:40 PM
Rocket Pharmaceuticals to Join NASDAQ Biotechnology IndexRocket Pharmaceuticals to Join NASDAQ Biotechnology Index
finance.yahoo.com - December 21 at 9:13 AM
Rocket Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares - Business WireRocket Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Business Wire
www.businesswire.com - December 1 at 9:33 AM
Rocket Pharma closes $63M capital raiseRocket Pharma closes $63M capital raise
seekingalpha.com - November 30 at 4:47 PM
Rocket Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional SharesRocket Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - November 30 at 4:47 PM
Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) and Fast Track Designations for RP-L102 Gene Therapy for Fanconi Anemia - Business WireRocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) and Fast Track Designations for RP-L102 Gene Therapy for Fanconi Anemia - Business Wire
www.businesswire.com - November 29 at 9:42 AM
RTW Investments Announces Private Placement Transaction with Rocket Pharmaceuticals, Inc. - Business WireRTW Investments Announces Private Placement Transaction with Rocket Pharmaceuticals, Inc. - Business Wire
www.businesswire.com - November 29 at 9:42 AM
Rocket Pharma prices stock offering at $15.50Rocket Pharma prices stock offering at $15.50
seekingalpha.com - November 28 at 9:35 AM
RTW Investments Announces Private Placement Transaction with Rocket Pharmaceuticals, Inc.RTW Investments Announces Private Placement Transaction with Rocket Pharmaceuticals, Inc.
www.marketwatch.com - November 28 at 9:35 AM
Rocket Pharma nabs $15M in new capital in private transactionRocket Pharma nabs $15M in new capital in private transaction
seekingalpha.com - November 28 at 9:35 AM
Rocket Pharma Grounded Despite Positive FDA UpdateRocket Pharma Grounded Despite Positive FDA Update
247wallst.com - November 27 at 4:33 PM
Rocket Pharmaceuticals receives RMAT and Fast Track designations for RP-L102Rocket Pharmaceuticals receives RMAT and Fast Track designations for RP-L102
seekingalpha.com - November 27 at 9:47 AM
Rocket Pharma (RCKT) Announces Preclinical Data for AAV-Based RP-A501 to Treat Monogenic Heart Failure SyndromeRocket Pharma (RCKT) Announces Preclinical Data for AAV-Based RP-A501 to Treat Monogenic Heart Failure Syndrome
www.streetinsider.com - November 26 at 4:43 PM
Rocket Pharma up 8% on advancement of AAV gene therapy for Danon diseaseRocket Pharma up 8% on advancement of AAV gene therapy for Danon disease
seekingalpha.com - November 26 at 4:43 PM
This page was last updated on 6/19/2019 by MarketBeat.com Staff

Featured Article: Preferred Stock

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel